{
    "2018-09-06": [
        [
            {
                "time": "",
                "original_text": "48家上市公司械企，赚钱能力大比拼！",
                "features": {
                    "keywords": [
                        "上市公司",
                        "器械企业",
                        "盈利能力"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2018年医药行业中报总结分析：暂时无方向性自下而上选择为主",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中报",
                        "总结分析",
                        "自下而上"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "以乐普生物为基石重点打造肿瘤免疫治疗平台",
                "features": {
                    "keywords": [
                        "乐普生物",
                        "肿瘤免疫",
                        "治疗平台"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【医药】乐普医疗：肿瘤免疫治疗布局高瞻远瞩，有望成为未来业绩重要驱动力",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "肿瘤免疫",
                        "布局",
                        "业绩驱动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:基药目录大调整,国务院下令增补187个品种",
                "features": {
                    "keywords": [
                        "医药行业",
                        "基药目录",
                        "政策调整",
                        "增补品种"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}